If you have any existing medical conditions, such as heart disease or diabetes, you may not be a good candidate for the procedure
GLP-1 receptor agonists work by: Stimulating insulin secretion from pancreatic beta cells in a glucose-dependent manner, which helps regulate blood sugar levels Slowing gastric emptying , meaning food remains in the stomach longer, promoting feelings of fullness Acting on appetite centres in the brain , particularly the hypothalamus, to reduce hunger signals and food cravings Decreasing glucagon secretion , which helps prevent excessive glucose production by the liver Most GLP-1 agonists are administered via subcutaneous injection, typically once weekly or once daily depending on the specific formulation, though oral semaglutide (Rybelsus) is also available
A detailed investigation on how the acetylation effects the functional activity of these proteins is yet to be conducted
Hermanowicz, A., Nawarska, Z., Borys, D
With growing awareness around metabolic health as the foundation of visible aging, MOTS-c is poised to become part of advanced anti-aging bundles
